A 62

New York Assembly Bill
2023 Regular Session

Introduced in Assembly
Assembly
Senate
Governor

Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology

View Latest Bill Text

Sign In to Follow

Abstract

Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.

Bill Sponsors (1)

Nader Sayegh

Democratic
Assembly Member
District 90

Votes

No votes to display

Actions

Jan 03, 2024

Assembly

REFERRED TO INSURANCE

Jan 04, 2023

Assembly

REFERRED TO INSURANCE

Bill Text

Bill Text Versions	Format
A62	PDF HTML

Related Documents

Document	Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.